Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-004881
Filing Date
2020-02-18
Accepted
2020-02-18 16:24:21
Documents
1
Period of Report
2020-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4140
  Complete submission text file 0000899243-20-004881.txt   5541
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Issuer) CIK: 0001563880 (see all company filings)

EIN.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TREVI THERAPEUTICS, INC. 195 CHURCH STREET, FLOOR 14 NEW HAVEN CT 06510
Business Address
Brett-Smith Helena (Reporting) CIK: 0001774731 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38886 | Film No.: 20625641